Redmile Group as of March 31, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 70 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 15.7 | $502M | 13M | 38.77 | |
| Amicus Therapeutics (FOLD) | 6.6 | $212M | 22M | 9.47 | |
| Argenx Se Sponsored Adr (ARGX) | 5.1 | $163M | 516k | 315.31 | |
| Livanova SHS (LIVN) | 5.0 | $161M | 2.0M | 81.83 | |
| Krystal Biotech (KRYS) | 3.8 | $121M | 1.8M | 66.54 | |
| Kymera Therapeutics (KYMR) | 3.5 | $111M | 2.6M | 42.32 | |
| Adc Therapeutics Sa SHS (ADCT) | 3.4 | $109M | 7.4M | 14.69 | |
| Science 37 Holdings | 3.3 | $106M | 20M | 5.35 | |
| Beam Therapeutics (BEAM) | 3.3 | $105M | 1.8M | 57.30 | |
| The Beauty Health Company Com Cl A (SKIN) | 2.8 | $90M | 5.3M | 16.88 | |
| Igm Biosciences (IGMS) | 2.8 | $89M | 3.3M | 26.73 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $70M | 2.0M | 34.06 | |
| Absci Corp (ABSI) | 2.1 | $68M | 8.0M | 8.43 | |
| Regenxbio Inc equity us cm (RGNX) | 2.0 | $66M | 2.0M | 33.19 | |
| Seagen | 2.0 | $64M | 441k | 144.05 | |
| Replimune Group (REPL) | 2.0 | $63M | 3.7M | 16.98 | |
| Atara Biotherapeutics | 1.8 | $58M | 6.2M | 9.29 | |
| Centene Corporation (CNC) | 1.7 | $55M | 649k | 84.19 | |
| ImmunoGen | 1.4 | $44M | 9.2M | 4.76 | |
| Stoke Therapeutics (STOK) | 1.3 | $43M | 2.0M | 21.05 | |
| Nurix Therapeutics (NRIX) | 1.3 | $42M | 3.0M | 14.01 | |
| Augmedix (AUGX) | 1.3 | $42M | 14M | 2.94 | |
| Verve Therapeutics (VERV) | 1.3 | $42M | 1.8M | 22.82 | |
| Anthem (ELV) | 1.3 | $41M | 83k | 491.22 | |
| Repare Therapeutics Ord (RPTX) | 1.2 | $39M | 2.7M | 14.24 | |
| 1life Healthcare | 1.2 | $38M | 3.4M | 11.08 | |
| Oak Street Health | 1.0 | $32M | 1.2M | 26.88 | |
| Tandem Diabetes Care Com New (TNDM) | 1.0 | $32M | 271k | 116.29 | |
| Somalogic Class A Com | 1.0 | $31M | 3.9M | 8.02 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $31M | 2.4M | 12.89 | |
| Invitae (NVTAQ) | 0.9 | $30M | 3.8M | 7.97 | |
| Nevro (NVRO) | 0.9 | $30M | 411k | 72.33 | |
| Gritstone Oncology Ord (GRTSQ) | 0.9 | $28M | 6.9M | 4.12 | |
| UnitedHealth (UNH) | 0.9 | $27M | 53k | 509.96 | |
| Prothena Corp SHS (PRTA) | 0.8 | $27M | 736k | 36.57 | |
| Iveric Bio | 0.8 | $25M | 1.5M | 16.83 | |
| Shattuck Labs (STTK) | 0.7 | $24M | 5.6M | 4.26 | |
| Stevanato Group S P A Ord Shs (STVN) | 0.7 | $23M | 1.2M | 20.12 | |
| Akero Therapeutics (AKRO) | 0.7 | $23M | 1.6M | 14.19 | |
| Pliant Therapeutics (PLRX) | 0.7 | $22M | 3.1M | 7.01 | |
| ICU Medical, Incorporated (ICUI) | 0.7 | $22M | 97k | 222.64 | |
| Entrada Therapeutics (TRDA) | 0.6 | $18M | 2.0M | 9.39 | |
| Bioventus Com Cl A (BVS) | 0.6 | $18M | 1.3M | 14.10 | |
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $18M | 3.5M | 5.26 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $18M | 115k | 155.67 | |
| Oncology Institu (TOI) | 0.5 | $17M | 2.4M | 7.13 | |
| Rapt Therapeutics | 0.5 | $17M | 749k | 21.99 | |
| Allakos | 0.5 | $15M | 2.6M | 5.70 | |
| Zymeworks | 0.4 | $14M | 2.1M | 6.55 | |
| Alx Oncology Hldgs (ALXO) | 0.4 | $13M | 772k | 16.90 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.4 | $12M | 2.8M | 4.40 | |
| Medavail Holdings Ord | 0.3 | $11M | 11M | 0.97 | |
| Hookipa Pharma Inc equity | 0.3 | $11M | 4.6M | 2.28 | |
| Adagio Therapeutics (IVVD) | 0.3 | $8.8M | 1.9M | 4.56 | |
| Annexon (ANNX) | 0.3 | $8.7M | 3.2M | 2.73 | |
| Alpha Teknova (TKNO) | 0.2 | $7.8M | 568k | 13.81 | |
| Neoleukin Therapeutics | 0.2 | $6.5M | 3.5M | 1.88 | |
| Deciphera Pharmaceuticals | 0.2 | $6.2M | 665k | 9.27 | |
| Immatics SHS (IMTX) | 0.2 | $5.8M | 725k | 7.99 | |
| Allovir (ALVR) | 0.2 | $5.6M | 823k | 6.75 | |
| Stereotaxis Com New (STXS) | 0.2 | $5.5M | 1.5M | 3.73 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $4.7M | 1.6M | 2.94 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $3.0M | 1.1M | 2.76 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $2.7M | 1.0M | 2.56 | |
| Atreca Cl A Com (BCEL) | 0.1 | $2.5M | 800k | 3.17 | |
| Sonendo (SONX) | 0.1 | $2.0M | 498k | 4.01 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $1.8M | 450k | 3.98 | |
| Cabaletta Bio (CABA) | 0.0 | $1.4M | 696k | 2.03 | |
| Cytosorbents Corp Com New (CTSO) | 0.0 | $850k | 266k | 3.19 | |
| Epizyme | 0.0 | $523k | 455k | 1.15 |